Search

iRhythm Technologies Inc

Geschlossen

BrancheGesundheitswesen

125.36 2.39

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

120.6

Max

127.93

Schlüsselkennzahlen

By Trading Economics

Einkommen

14M

-381K

Verkäufe

25M

224M

EPS

0.58

Gewinnspanne

-0.17

Angestellte

2,400

EBITDA

6.5M

2.9M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+41.91% upside

Dividenden

By Acuity

Nächstes Ergebnis

29. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

16M

4.1B

Vorheriger Eröffnungskurs

122.97

Vorheriger Schlusskurs

125.36

Nachrichtenstimmung

By Acuity

11%

89%

16 / 340 Ranking in Healthcare

iRhythm Technologies Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Aug. 2026, 20:06 UTC

News

iRhythm Technologies reports second-quarter revenue of $224.17 million and updates full-year guidance. Shares are higher since Thursday's close despite earlier session declines.

13. Aug. 2026, 20:06 UTC

News

iRhythm Technologies reported second-quarter revenue of $224.2 million, exceeding estimates, but shares are trading lower during Thursday's session.

12. Aug. 2026, 19:56 UTC

iRhythm Technologies Inc. shares are higher Wednesday, reflecting positive market conditions despite earlier session pullbacks and recent downward pressure.

11. Aug. 2026, 20:06 UTC

iRhythm Technologies shares are lower today, continuing a downward trend since Monday's close, despite stabilizing above the 20-day moving average.

10. Aug. 2026, 19:41 UTC

News

iRhythm Technologies shares lower today despite Truist raising the price target to $168.00 and reporting Q2 sales of $224.2 million.

7. Aug. 2026, 19:51 UTC

News

iRhythm Technologies is higher today, driven by strong earnings of $224.17 million and its acquisition of VitalConnect for $287.5 million.

6. Aug. 2026, 23:02 UTC

News

iRhythm Technologies shares rise in after-market trading following strong Q2 results, $224.2 million in revenue, and an acquisition of VitalConnect for $287.5 million.

5. Aug. 2026, 19:46 UTC

News

iRhythm Technologies shares are lower amid cautious market sentiment following ADP's report of disappointing private sector job growth. Earnings are due August 6.

4. Aug. 2026, 21:01 UTC

iRhythm Technologies Inc shares rose in after-market hours, reflecting a broader market rally amid positive sentiment from U.S.-Iran negotiations and falling crude oil prices.

3. Aug. 2026, 20:03 UTC

iRhythm Technologies Inc shares are rising, driven by gains in the Health Care Equipment sub-sector and overall strong market performance.

31. Juli 2026, 21:01 UTC

iRhythm Technologies Inc shares advanced in after-hours trading, reflecting unusual strength amid rising inflation concerns and geopolitical tensions affecting oil prices.

30. Juli 2026, 19:43 UTC

iRhythm Technologies Inc is lower today, influenced by declines in the Health Care Equipment sub-sector. This follows five consecutive sessions of gains.

29. Juli 2026, 19:52 UTC

Macro Event

iRhythm Technologies shares are higher today, reflecting positive momentum after the Federal Reserve maintained interest rates amid easing inflation concerns.

28. Juli 2026, 18:03 UTC

iRhythm Technologies is higher today, driven by gains in the Health Care Equipment sub-sector. Shares pulled back from earlier session highs.

27. Juli 2026, 20:06 UTC

iRhythm Technologies Inc shares are higher amid positive market sentiment, driven by a decline in oil prices and easing geopolitical tensions.

24. Juli 2026, 20:06 UTC

iRhythm Technologies Inc shares are trading higher, reflecting positive sentiment amid falling oil prices that ease inflation concerns. No specific company news was identified.

23. Juli 2026, 09:01 UTC

iRhythm Technologies Inc is trading higher in pre-market hours, reflecting a notable gain since Wednesday's close. No specific news was identified for this movement.

21. Juli 2026, 18:56 UTC

News

iRhythm Technologies is under investigation for potential wrongdoing by certain officers and directors, contributing to lower trading during Tuesday's session.

20. Juli 2026, 19:16 UTC

iRhythm Technologies Inc is trading higher Monday, having reached a peak cumulative return earlier in the session. No specific news was identified to explain the movement.

Peer-Vergleich

Kursveränderung

iRhythm Technologies Inc Prognose

Kursziel

By TipRanks

41.91% Vorteil

12-Monats-Prognose

Durchschnitt 174.78 USD  41.91%

Hoch 196 USD

Tief 157 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für iRhythm Technologies Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

11

Buy

0

Halten

0

Sell

Stimmung

By Acuity

16 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat